PolyPid PYPD
NASDAQ PYPD
$5.13 +0.06 (+1.18%)
At close: Oct 22, 2026 · 4:00 PM EDT

PolyPid (PYPD) Preferred Stock Liabilities (2019 - 2020)

Updated

PolyPid (PYPD) posted Preferred Stock Liabilities of $106.31 million for Q4 2020, unchanged from $106.31 million a year earlier.

Analysis

PolyPid (PYPD) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

  • In prior years, PolyPid's Preferred Stock Liabilities was $106.31 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 PolyPid 83.56 Mn 52.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 106.31 Mn
Dec 31, 2019 106.31 Mn
API Access

PolyPid Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PYPD&period=max&api_key=YOUR_API_KEY